Prescribed Benzodiazepines and Suicide Risk: A Review of the Literature
The DOI matches its Crossref record.
Abstract
OBJECTIVE: To evaluate whether prescribed benzodiazepines affect one's risk of suicide. DATA SOURCES: A PubMed search of English-language publications from database inception until October 11, 2016, was conducted using the terms benzodiazepine and suicide. References and related articles were also searched to yield additional publications. STUDY SELECTION/DATA EXTRACTION: Studies were included if they addressed the relationship between suicidal behavior and the prescribed use of either specific benzodiazepines or benzodiazepines as a class. A total of 17 studies were included in this review. RESULTS: The majority of studies found that benzodiazepines were associated with increased suicide risk. This finding was consistent across various populations and different types of research, including a placebo-controlled crossover trial, a laboratory model of suicidal behavior, case-control studies regarding completed suicides on inpatient units, and large naturalistic studies. CONCLUSIONS: Benzodiazepines appear to cause an overall increase in the risk of attempting or completing suicide. Possible mechanisms of prosuicidal effects may include increases in impulsivity or aggression, rebound or withdrawal symptoms, and toxicity in overdose.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Long-term BZD use is associated with an increased risk of physical dependence and withdrawal and ongoing risk of adverse events such as falls, motor vehicle accidents, and cognitive impairment.3,11–13”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [13]
In the citing paper
“Evidence also suggests that use of BZDs is associated with increased suicide risk, although the mechanism for this association is not well understood.12,13”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [13]
In the citing paper
“The dose of BZD given also positively correlated with increased risk of an overdose death [50].”
From Benzodiazepines: Uses, Dangers, and Clinical Considerations (2021) · cites this paper as [50]
In the citing paper
“A study investigating the prescription of opioids and BZD in veterans showed an increased risk of overdose death in veterans who have prescriptions for both BZD and opioids at the same time [50].”
From Benzodiazepines: Uses, Dangers, and Clinical Considerations (2021) · cites this paper as [50]
In the citing paper
“First, BZD have been associated with worse mood outcomes long-term and may increase suicidality in vulnerable patients with other psychiatric risk-factors.141, 142, 143, 144”
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cited by
Epidemiology of suicide and the psychiatric perspective
Bachmann, S. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15071425 · Cited by 1,377
Prescribed drugs containing nitrogen heterocycles: an overview
Heravi, M. M., & Zadsirjan, V. (2020) · RSC Advances · doi:10.1039/d0ra09198g · Cited by 1,194
Benzodiazepines: Uses, Dangers, and Clinical Considerations
Edinoff, A. N., Nix, C. A., Hollier, J., Sagrera, C. E., Delacroix, B. M., Abubakar, T., Cornett, E. M., Kaye, A. M., & Kaye, A. D. (2021) · Neurology International · doi:10.3390/neurolint13040059 · Cited by 340
“The dose of BZD given also positively correlated with increased risk of an overdose death [50].”
BackgroundAnxiety disorders: a review of current literature
Thibaut, F. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.2/fthibaut · Cited by 213
Lähteenvuo, M., Tanskanen, A., Taipale, H., Hoti, F., Vattulainen, P., Vieta, E., & Tiihonen, J. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.4711 · Cited by 156
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Lähteenvuo, M., & Tiihonen, J. (2021) · Drugs · doi:10.1007/s40265-021-01556-4 · Cited by 222
Cutler, A. J., Mattingly, G. W., & Maletic, V. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02514-2 · Cited by 194
“These concerns, in addition to the risk of dependence and abuse [179] and an overall increase in the risk of attempting or completing suicide [180] may further limit the potential use of benzodiazepines in the treatment of depression [178].”
BackgroundThe role of prediction in suicide prevention
Large, M. M. (2018) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2018.20.3/mlarge · Cited by 99
Taipale, H., Lähteenvuo, M., Tanskanen, A., Mittendorfer-Rutz, E., & Tiihonen, J. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa111 · Cited by 85
Brandt, J., Bressi, J., Lê, M.-L., Neal, D., Cadogan, C., Witt-Doerring, J., Witt-Doerring, M., & Wright, S. (2024) · eClinicalMedicine · doi:10.1016/j.eclinm.2024.102507 · Cited by 77
Benzodiazepines and Related Sedatives
Peng, L., Morford, K. L., & Levander, X. A. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.08.012 · Cited by 88
Vӧllm, B., Edworthy, R., Huband, N., Talbot, E., Majid, S., Holley, J., Furtado, V. A., Weaver, T. D., McDonald, R., & Duggan, C. F. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00140 · Cited by 68
“It would also be useful to explore any relationship between benzodiazepine use and violent or suicidal behaviour, given that benzodiazepines can be associated with increased suicide risk [47], with paradoxical aggressive reactions [48, 49] and with violent behaviour in forensic patients [50, 51].”
BackgroundOn the Relationship between Classic Psychedelics and Suicidality: A Systematic Review
Zeifman, R. J., Singhal, N., Breslow, L., & Weissman, C. R. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00024 · Cited by 73
Selective serotonin reuptake inhibitors and suicidal behaviour: a population-based cohort study
Lagerberg, T., Fazel, S., Sjölander, A., Hellner, C., Lichtenstein, P., & Chang, Z. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01179-z · Cited by 61
Association between benzodiazepines and suicide risk: a matched case-control study
Cato, V., Holländare, F., Nordenskjöld, A., & Sellin, T. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2312-3 · Cited by 60
“While the suicide risk associated with BZDs is thought to be dose-dependent [32], it was not possible to analyze dosage in the current study and no information was available to demonstrate whether the individual retrieved the prescribed drug or not.”
BackgroundInfluentialGuillén, A. I., Marín‐Martín, C., Panadero, S., & Vázquez, J. J. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2019.106246 · Cited by 65
“Several recent systematic reviews (Dodds, 2017; McCall et al., 2016) have found a positive relationship between the consumption of sedatives and the risk of suicide.”
BackgroundBrunner, E., Chen, C.-Y. A., Klein, T., Maust, D., Mazer-Amirshahi, M., Mecca, M., Najera, D., Ogbonna, C., Rajneesh, K. F., Roll, E., et al. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09499-2 · Cited by 51
“12,13 The risk–benefit balance for continued BZD use may shift over time, and stopping can be challenging because physical dependence develops with regular use.”
Anxiety Screening: Evidence Report and Systematic Review for the US Preventive Services Task Force
O’Connor, E., Henninger, M. L., Perdue, L. A., Coppola, E. L., Thomas, R. G., & Gaynes, B. N. (2023) · JAMA · doi:10.1001/jama.2023.6369 · Cited by 52
Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey
Reid Finlayson, A. J., Macoubrie, J., Huff, C., Foster, D. E., & Martin, P. R. (2022) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253221082386 · Cited by 40
Tournier, M., Bénard‐Laribière, A., Jollant, F., Hucteau, E., Diop, P., Jarne‐Munoz, A., Pariente, A., Oger, E., & Bezin, J. (2023) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13582 · Cited by 35
“They might be causal, direct (disinhibition, cognitive impairment, dissociative behaviour, parasomnia) or indirect (depression, rebound insomnia or anxiety).(8,12) Moreover, as the relationship was shown cumulative in some studies, the role of repeated withdrawal or of long-term lowering of the brain activation level…”
BackgroundLimited Utility for Benzodiazepines in Chronic Pain Management: A Narrative Review
Wright, S. L. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01354-6 · Cited by 44
Concha, D. A., Lähteenvuo, M., Vattulainen, P., Tanskanen, A. J., Taipale, H. T., Vieta, E., & Tiihonen, J. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.016 · Cited by 39
“As these drugs along with anxiolytics might inhibit impulse control, possibly even after their hypnotic effect wears off, they might lead to increased translation from suicidal ideations to suicidal behaviors (Dodds, 2017, Sun et al., 2016).”
BackgroundDevelopment of a Suicide Prediction Model for the Elderly Using Health Screening Data
Cho, S., Geem, Z. W., & Na, K. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph181910150 · Cited by 40
“This is consistent with the results of previou tudies, according to which pre cription f benzodiazepi es alo e is associated with a high risk of suicide, even if not used as a means of suicide [33,34].”
ResultStith, S. S., Li, X., Diviant, J. P., Brockelman, F., Keeling, K., Hall, B., & Vigil, J. M. (2020) · Journal of Cannabis Research · doi:10.1186/s42238-020-00051-z · Cited by 36
“…psychiatric medications are associated with frequent and severe negative side effects (e.g., addiction and suicidality), adverse reactions, acute toxicity, and even risk of death (Dodds 2017; Kurlawala et al. 2018; MullerOerlinghausen and Berghofer 1999; Read and Williams 2018; Wick 2013).”
BackgroundDonovan, L. M., Malte, C. A., Spece, L. J., Griffith, M. F., Feemster, L. C., Engelberg, R. A., Au, D. H., & Hawkins, E. J. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201802-145oc · Cited by 30
Evidence for deprescription in primary care through an umbrella review
Lima, A. O. D. L., Marcos‐Marcos, J., Márquez, A. M., Vera, M. D. L. Á. G., Hoces, A. M., & Bermúdez‐Tamayo, C. (2020) · BMC Family Practice · doi:10.1186/s12875-020-01166-1 · Cited by 30
Pharmacological interventions for self-harm in adults
Witt, K., Hetrick, S. E., Rajaram, G., Hazell, P., Salisbury, T. T., Townsend, E., & Hawton, K. E. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013669.pub2 · Cited by 28
The Neuroscience of Suicidal Behavior
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205 · Cited by 45
Armoon, B., Mohammadi, R., Moghaddam, L. F., & Gonabadi-Nezhad, L. (2021) · Journal of Substance Use · doi:10.1080/14659891.2021.2019329 · Cited by 26
“The research identified the relationship between benzodiazepine prescription and the risk of suicide in patients (Dodds, 2017), as well as decreasing the dose of benzodiazepine and suicide risk (Okumura & Nishi, 2017).”
BackgroundHerrera‐Gómez, F., Gutiérrez‐Abejón, E., Criado-Espegel, P., & Alvarez, E. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00408 · Cited by 22
“, 2011), regardless of other causes of death among those using these medications (Dodds, 2017).”
BackgroundSuicide along the Australian coast: Exploring the epidemiology and risk factors
Lawes, J. C., Peden, A. E., Bugeja, L. C., Strasiotto, L., Daw, S., & Franklin, R. C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251938 · Cited by 24
“One potential exception to this may be the use of benzodiazepines, however the cause of this relationship is considered to be partially attributed to withdrawal and overdose, neither of which would have therapeutic levels and would already be covered under this methodology [44].”
BackgroundLee, H., Myung, W., Lee, C., Choi, J., Kim, H., Carroll, B. J., & Kim, D. K. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.01.018 · Cited by 26
A national case fatality study of drugs taken in intentional overdose
Daly, C., Griffin, E., Corcoran, P. E., Webb, R. T., Ashcroft, D. M., Perry, I. J., & Arensman, E. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.102609 · Cited by 25
Oldenhof, E., Anderson‐Wurf, J., Hall, K., & Staiger, P. K. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122143 · Cited by 22
“Since that time evidence of broad-ranging harms resulting from long-term BDZ use has continued to grow, including cognitive deficits [8–10], reductions in quality of life [11–13], depression [14–16], risk of suicide [17], risk for road accidents [18,19], and specific to older adults—the risk of falls [20–22], developi…”
BackgroundCulbreth, R. E., Swahn, M. H., Osborne, M. C., Brandenberger, K. J., & Kota, K. K. (2021) · Preventive Medicine · doi:10.1016/j.ypmed.2021.106682 · Cited by 17
Epidemiologic assessment of benzodiazepine exposure among suicide deaths in Colorado, 2015–2017
Ghosh, T., Bol, K., Butler, M., Gabella, B., Kingcade, A., Kaplan, G., & Myers, L. (2020) · BMC Public Health · doi:10.1186/s12889-020-09250-y · Cited by 17
Au, V. Y. O., Rosic, T., Sanger, N., Hillmer, A., Chawar, C., Worster, A., Marsh, D. C., Thabane, L., & Samaan, Z. (2021) · Harm Reduction Journal · doi:10.1186/s12954-021-00521-4 · Cited by 21
Association between opioid analgesic plus benzodiazepine use and death: A case-crossover study
Yang, B. R., Oh, I., Li, J., Jeon, H., & Shin, J. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.110153 · Cited by 18
Brandt, J., Janzen, D., Alessi‐Severini, S., Singer, A. G., Chateau, D. G., Enns, M. W., & Leong, C. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-046916 · Cited by 18
Sung, H. G., Li, J., Nam, J. H., Won, D. Y., Choi, B., & Shin, J. (2019) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-019-01713-x · Cited by 18
Boggs, J. M., Lindrooth, R. C., Battaglia, C. T., Beck, A. L., Ritzwoller, D. P., Ahmedani, B. K., Rossom, R. C., Lynch, F. L., Lu, C. Y., Waitzfelder, B. E., et al. (2019) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2019.11.005 · Cited by 15
“Similarly, a 2017 review of benzodiazepines and suicidal behavior indicated that nearly all studies examining the relationship between benzodiazepine and suicide showed positive associations for benzodiazepine use and suicide outcomes, but only two were well-controlled (Dodds, 2017).”
BackgroundKatz, C., Randall, J. R., Leong, C., Sareen, J., & Bolton, J. M. (2018) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2018.10.003 · Cited by 18
Associations between treatment with melatonin and suicidal behavior: a nationwide cohort study
Høier, N. K., Madsen, T., Spira, A. P., Hawton, K. E., Jennum, P., Nordentoft, M., & Erlangsen, A. (2022) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.10118 · Cited by 15
Lecat, N., Fourrier‐Réglat, A., Montagni, I., Tzourio, C., Pariente, A., Verdoux, H., & Tournier, M. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113276 · Cited by 15
Okino, K., Suzuki, H., Tomioka, H., Sanada, K., Kawai, K., Iwanami, A., & Inamoto, A. (2023) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2868 · Cited by 11
“Furthermore, recent studies have reported an association between the use of GABA‐BZ receptor agonists and suicide, as well as other serious adverse events (Bhaskaran et al., 2015; Dodds, 2017).”
BackgroundSleep Disorders in Women Veterans
Martin, J. L., Badr, M. S., & Zeineddine, S. (2018) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2018.04.010 · Cited by 11
Jeong, H. E., Jeon, H., Oh, I., Kim, W. J., & Shin, J. (2020) · BMC Medicine · doi:10.1186/s12916-020-01854-w · Cited by 16
“several systematic reviews of observational studies and randomized trials found BZD use to be positively associated with suicides [26, 27], accidents [28], or falls [29].”
BackgroundDemesmaeker, A., Chazard, E., Vaïva, G., & Amad, A. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.04.006 · Cited by 12
Saito, N., Itoga, M., Minakawa, S., & Kayaba, H. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s300517 · Cited by 12
Chris Cornell, the Black Hole Sun, and the Seasonality of Suicide
Schwartz, P. J. (2019) · Neuropsychobiology · doi:10.1159/000498868 · Cited by 11
Strømme, M. F., Augustsson, M. T., Bartz-Johannessen, C. A., Stautland, A., Mykletun, A., Kroken, R. A., Mehlum, L. I., Kjelby, E., & Johnsen, E. (2024) · Psychological Medicine · doi:10.1017/s0033291724002873 · Cited by 11
Vandenbosch, M., Somers, T., & Cuypers, E. (2019) · Drug Testing and Analysis · doi:10.1002/dta.2578 · Cited by 9
Trager, R. J., Cupler, Z. A., Delano, K. J., Perez, J. A., & Dusek, J. A. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-058769 · Cited by 9
The Psychiatric Characteristics of People on a Mephedrone (“bath salts”) Binge
Ordak, M., Nasierowski, T., Muszyńska, E., & Bujalska‐Zadrożny, M. (2020) · Substance Use & Misuse · doi:10.1080/10826084.2020.1753775 · Cited by 9
“benzodiazepines, significantly increases the risk of a suicide attempt (Dodds, 2017).”
BackgroundRisk factors for fatal drowning in a Greek region: a retrospective case–control study
Kevrekidis, D. P., Brousa, E., Mastrogianni, O., Orfanidis, A., Gika, H., & Raikos, Ν. (2020) · Injury Prevention · doi:10.1136/injuryprev-2020-043788 · Cited by 10
Drug Safety and Suicidality Risk of Chronic Pain Medications
Syed, O., Jancic, P., Fink, A. B., & Knežević, N. N. (2023) · Pharmaceuticals · doi:10.3390/ph16101497 · Cited by 12
Lee, J., Lim, J., Kim, S. H., Kim, J., Mun, K. H., & Kang, J. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.03.045 · Cited by 9
Acute Carbamazepine Intoxication
Gallego, M. D. C., & García, M. A. (2022) · Neurology International · doi:10.3390/neurolint14030049 · Cited by 8
“Discussion Acute intoxication by carbamazepine at high doses is a rare clinical event, being more common the presence of intoxications with other types of toxic substances such as benzodiazepines [12] or alcohol [13,14], however, in a patient with an abnormal neurological situation and with concomitant antiepileptic d…”
BackgroundLópez‐Castromán, J., Jaussent, I., Gorwood, P. A. P. M., & Courtet, P. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109762 · Cited by 9
Hasanah, A. N., Susanti, I., Marcellino, M., Maranata, G. J., Saputri, F. A., & Pratiwi, R. (2021) · Open Chemistry · doi:10.1515/chem-2021-0050 · Cited by 11
“These receptors are found in the central nervous system and explain the mechanism of the sedative effect of DZP to reduce stress and induce drowsiness [1].”
BackgroundSoboka, M., Stewart, S. H., Tibbo, P. G., & Wang, J. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-086487 · Cited by 16
Suicide by Opioid: Exploring the Intentionality of the Act
Pergolizzi, J. V., Breve, F., Magnusson, P., Nalamasu, R., LeQuang, J. A., & Varrassi, G. (2021) · Cureus · doi:10.7759/cureus.18084 · Cited by 6
Drug-induced psychiatric disorders: A pharmacovigilance update
Montastruc, F., & de Laportalière, T. T. (2023) · Therapies · doi:10.1016/j.therap.2023.09.007 · Cited by 11
Cabrera‐Mendoza, B., Martínez‐Magaña, J. J., Monroy‐Jaramillo, N., Mendoza, A. D. G., Fresno, C., Fries, G. R., Walss‐Bass, C., López‐Armenta, M., García‐Dolores, F., Díaz‐Otañez, C. E., et al. (2021) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32830 · Cited by 7
Gouraud, C., Airagnes, G., Kab, S., Courtin, É., Goldberg, M., Limosin, F., Lemogne, C., & Zins, M. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044891 · Cited by 8
Suicidal behaviors among intravenous drug users: a meta-analysis
Armoon, B., Fleury, M., Bayani, A., Mohammadi, R., Ahounbar, E., & Griffiths, M. D. (2022) · Journal of Substance Use · doi:10.1080/14659891.2022.2120435 · Cited by 11
“Using them in combination with other depressants such as alcohol or opioids can cause lethal respiratory suppression and fatal drug overdoses (Armoon, Mohammadi, et al., 2021; Armoon et al., 2022; Dodds, 2017).”
BackgroundOgeil, R. P., Witt, K., Scott, D., Smith, K. L., & Lubman, D. I. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.158 · Cited by 6
One-Pot, Water-Mediated, H2O2-HCl Catalyzed Synthesis of Benzazepines
Singh, N., & Pandey, J. (2020) · Asian Journal of Chemistry · doi:10.14233/ajchem.2020.22574 · Cited by 6
Murugaiyan, S. M., & Bhargavan, R. (2020) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2019-0379 · Cited by 7
Marschall, J. S., Kushner, G. M., & Alpert, B. (2020) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2020.04.003 · Cited by 6
Aporosa, S., Itoga, D., Ioane, J., Prosser, J., Vaka, S., Grout, E., Atkins, M. J., Head, M. A., Baker, J. D., Blue, T., et al. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1460731 · Cited by 10
Choi, N. G., Choi, B. Y., Marti, C. N., & Baker, D. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1505040 · Cited by 6
Khan, S. M., Kasagga, A., Verma, A., Saraya, E., Haque, M. S., Senaratne, M., & Khan, S. (2025) · Cureus · doi:10.7759/cureus.84318 · Cited by 7
Benzodiazepine consumption in Brazil: considerations regarding a population-specific scenario
Dokkedal‐Silva, V., Galduróz, J. C. F., Tufik, S., & Andersen, M. L. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2019-0830 · Cited by 6
Saini, S., Tahlan, S., & Minocha, N. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266296096240408032738 · Cited by 5
Tanskanen, T. E., Wegelius, A., Härkönen, T., Gummerus, E.-M., Stenberg, J., Selinheimo, S., Alakuijala, A., Tenhunen, M. L., Paajanen, T. I., Järnefelt, H., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-076129 · Cited by 4
“46 The use of CBT-I instead of sleep medication is likely to be advantageous for long-term health.”
BackgroundNagashima, K., Sumida, M., Imanaka, S., Kuwabara, T., Kaneko, I., Miyake, Y., Yasuno, N., Itagaki, F., & Watanabe, M. (2021) · Journal of Pharmaceutical Health Care and Sciences · doi:10.1186/s40780-021-00217-8 · Cited by 5
Almeida‐González, M., Boada, L. D., Henríquez‐Hernández, L. A., Luzardo, O. P., Zaragoza, E., Putze, G. B., Montesdeoca, M. D. P. Q., & Zumbado, M. L. (2022) · Toxics · doi:10.3390/toxics10020064 · Cited by 5
“More recently, an association between medical prescription of BZDs and an increased risk of suicide has been described [9,10].”
BackgroundNowels, M., Duberstein, P. R., Crystal, S., Treitler, P. C., Miles, J., Olfson, M., & Samples, H. (2023) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2023.11.003 · Cited by 4
Ngoc, P. V., Ceuterick, M., Belche, J.-L., & Scholtes, B. (2024) · International Journal of Qualitative Studies on Health and Well-Being · doi:10.1080/17482631.2024.2424013 · Cited by 7
Brådvik, L., Löwenhielm, P., Frank, A., & Berglund, M. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16050801 · Cited by 8
“According to a recent review of 17 studies, a positive correlation between prescription benzodiazepines and non-fatal and fatal suicidal behaviour was reported in most studies, with few exceptions [42].”
BackgroundXu, X., Wang, X., Zhong, N., Xu, J., Li, C., Wang, G., Wang, W., Ye, Y., Chen, Y., Liu, T., et al. (2022) · BJPsych Open · doi:10.1192/bjo.2022.589 · Cited by 4
Andrade, C. (2020) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.20f13238 · Cited by 5
Hwang, S.-B., Lee, J.-G., Lee, Y., Kook, W.-A., Kim, S., Donio, A. L., Min, H.-W., Kim, Y., Lee, S., & Jang, C. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00346 · Cited by 3
Mother's little helper turned a foe: Alprazolam use, misuse, and abuse
Cardona-Acosta, A. M., Meisser, N., Vardeleon, N. I., Steiner, H., & Bolaños‐Guzmán, C. A. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111137 · Cited by 5
Ishihara, Y., Sugawara, N., Kawamata, Y., & Yasui‐Furukori, N. (2024) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12507 · Cited by 3
“Additionally, BZDs may elevate the risk of suicide, particularly in patients with guilty feelings, 32 offering another potential explanation for the observed prescribing patterns.”
Chapter 20. Neurobiology and Treatment of Sedative-, Hypnotic-, and Anxiolytic-Related Disorders
Jones, J. L., VandenBerg, A., & Malcolm, R. J. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373970.kb20 · Cited by 3
Hsiao, S., Cheng, C., Lin, I.-J., Yu, C.-P., Huang, Y.-C., Huang, S.-H., Sun, C., Fann, L.-Y., Sheu, M.-Y., & Chien, W. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192013169 · Cited by 7
“People who have attempted suicide have a relatively high risk of future suicide attempts [11].”
BackgroundLagerberg, T., Sjölander, A., Gibbons, R. D., Quinn, P. D., D'Onofrio, B. M., Hellner, C., Lichtenstein, P., Fazel, S., & Chang, Z. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1012650 · Cited by 4
Nielssen, O. B., Staples, L., Karin, E., Ryan, K., Kayrouz, R., Dear, B. F., Cross, S. P. M., & Titov, N. (2023) · BJPsych Open · doi:10.1192/bjo.2023.60 · Cited by 3
Ju, Y., Liu, Y., Tan, L., & Su, L. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.05.029 · Cited by 3
Clinical picture of benzodiazepine dependence: The role of different types of benzodiazepines
Žikić, O., Nikolić, G., & Kostić, J. (2019) · Journal of Substance Use · doi:10.1080/14659891.2019.1581283 · Cited by 4
“Rebound or withdrawal symptoms also may contribute to suicidal risk (Dodds, 2017).”
BackgroundSilczuk, A., & Heitzman, J. (2020) · Psychiatria Polska · doi:10.12740/pp/115555 · Cited by 3
“, acute withdrawal syndrome [26, 27], and due to possible harm associated with their use, it is recommended to discon-”
BackgroundSurviving Benzodiazepines: A Patient’s and Clinician’s Perspectives
Silvernail, C. M., & Wright, S. L. (2022) · Advances in Therapy · doi:10.1007/s12325-022-02055-y · Cited by 3
Assessing suicide risk in chronic pain management: a narrative review across drug classes
Brezić, N., Gligorevic, S., Candido, K. D., & Knežević, N. N. (2024) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2024.2391999 · Cited by 2
“Moreover, recent BZD use consistently correlates with increased risk of suicide attempts and completed suicides [130–132].”
Seifert, J., Bleich, S., & Seifert, R. (2025) · Springer eBooks · doi:10.1007/978-3-662-70594-0_22 · Cited by 3
Stress, Vulnerability, and Suicide: The Stress–Diathesis Model
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.003 · Cited by 3
Risk factors for suicide among veterans living with and without HIV: a nested case-control study
Smith, A. C., Goulet, J. L., Vlahov, D., Justice, A. C., & Womack, J. A. (2023) · AIDS and Behavior · doi:10.1007/s10461-023-04164-3 · Cited by 2
“The included terms were selected a priori based on previous literature identifying their role in the potentiation of adverse outcomes among PWH [16, 17, 29–33].”
Schaffer, A. L., Buckley, N. A., Schumann, J., Lim, J. S., Cairns, R. F., Raubenheimer, J., Pearson, S., & Chitty, K. M. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102858 · Cited by 2
Islam, M. T., Molla, S., Zihad, S. M. N. K., Umer, M., Rahman, M. S., Zaman, F., Das, A. K., Afzal, M. I., Salehi, B., Akter, M. S., et al. (2020) · Cellular and Molecular Biology · doi:10.14715/cmb/2020.66.4.3 · Cited by 2
“It additionally has some serious side effects, including suicide, decreased breathing, and an increased seizures risk whether frequently used in epileptic patients (7,10).”
Background
Metadata
- Authors
- Dodds, T. J.
- Affiliations
- Austen Riggs Center (US)
- Corresponding author
- Dodds, Tyler J.
- ORCID
- Dodds, Tyler J.
- Venue
- The Primary Care Companion For CNS Disorders
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2017-03-02
- Volume
- 19
- Issue
- 2
- ISSN
- 2155-7772 (ISSN-L)
- 2155-7780
- OpenAlex
- W2592924765
- Cited by
- 144
- References
- 0
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 14 · 2023: 12 · 2022: 14 · 2021: 23 · 2020: 19 · 2019: 13 · 2018: 27 · 2017: 1
- FWCI
- 20.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Primary Care Companion For CNS Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- benzodiazepines, suicide risk, suicidal behavior, suicide attempts, suicide completion, impulsivity, benzodiazepine overdose
- MeSH terms
- Benzodiazepines, Humans, Risk, Suicide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.